Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Operating Expenses (2019 - 2026)

Revolution Medicines (RVMD) posted Operating Expenses of $505.1 million for Q2 2026, up 13.46% on a QoQ basis from $445.2 million in Q1 2026, and up 90.82% year-over-year from $264.7 million in Q2 2025.

Analysis

Revolution Medicines (RVMD) Operating Expenses (2019 - 2026) Analysis & Trends

Revolution Medicines has reported Operating Expenses for 8 years, with the latest figure at $505.1 million in Q2 2026.

  • On a quarterly basis, Operating Expenses rose 90.82% year-over-year to $505.1 million in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 81.31% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 71.48% from the prior year.
  • Operating Expenses was $505.1 million for Q2 2026 at Revolution Medicines, up from $445.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $505.1 million in Q2 2026, with the low at $65.5 million in Q1 2022.
  • Average Operating Expenses over 5 years is $200.8 million, with a median of $166.2 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 134.6% in 2023, then gained 19.69% in 2024.
  • Over 5 years, Operating Expenses stood at $77.0 million in 2022, then soared by 134.6% to $180.7 million in 2023, then rose by 19.69% to $216.3 million in 2024, then surged by 67.18% to $361.6 million in 2025, then jumped by 39.68% to $505.1 million in 2026.
  • The last three Operating Expenses figures came in at $505.1 million (Q2 2026), $445.2 million (Q1 2026), and $361.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 10.12 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 10.56 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -9.70 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 18.20 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 2.09 Bn
10 Revolution Medicines 40.86 Bn 40.86 Bn - 505.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 505.13 Mn
Mar 31, 2026 445.22 Mn
Dec 31, 2025 361.63 Mn
Sep 30, 2025 315.27 Mn
Jun 30, 2025 264.71 Mn
Mar 31, 2025 240.76 Mn
Dec 31, 2024 216.31 Mn
Sep 30, 2024 175.71 Mn
Jun 30, 2024 156.64 Mn
Mar 31, 2024 140.86 Mn
Dec 31, 2023 180.73 Mn
Sep 30, 2023 123.25 Mn
Jun 30, 2023 112.62 Mn
Mar 31, 2023 82.17 Mn
Dec 31, 2022 77.04 Mn
Sep 30, 2022 79.89 Mn
Jun 30, 2022 71.21 Mn
Mar 31, 2022 65.53 Mn
Dec 31, 2021 62.37 Mn
Sep 30, 2021 54.26 Mn
API Access

Revolution Medicines Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEY